Nathan Denlinger, DO, discusses real-world data with second-line liso-cel and axi-cel in patients with relapsed/refractory large B-cell lymphoma.
Nathan Denlinger, DO
Advertisement
Nathan Denlinger, DO, is a physician and assistant professor of hematology in the Department of Internal Medicine at The Ohio State University Comprehensive Cancer Center—James
Articles by Nathan Denlinger, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5